For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    By product type
    Proteins and Peptides
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

p65 and the NF-κB inflammatory pathway

Related

  • NF-kB resources
    • Overview of NF-κB signaling
      • NF-κB interactive pathway
        • p65 post-translational modifications
          • Methods to study transcription factor activation
              • p65 products
                • KO-validated anti-NF-κB p65 antibody
                  • NF-κB p65 transcription factor assay kit
                    • NF-κB p65 ELISA kit
                      • Recombinant human NF-κB p65 protein
                          • Secondary antibodies
                            • Alexa Fluor® conjugated
                              • Anti-Rabbit IgG Alexa Fluor® 488 (ab150077)
                              • HRP conjugated
                                • Anti-Rabbit IgG (HRP) (ab205718)

                                ​​By David Bruce, PhD


                                p65, also known as RelA, is one of the five components that form the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) transcription factor family.

                                The remaining members include RelB, c-Rel, and cleaved proteins NF-κB1 (p50) and NF-κB2 (p52). p50 and p65 form the most common heterodimer in the NF-κB signaling pathway, present in most cell types. In contrast, other members, for example, c-Rel, are predominantly found only in hematopoietic cells (Napetschnig and Wu, 2013; Bassères and Baldwin, 2006).

                                p65, RelB, and c-Rel are characterized by a Rel homology domain located in the N-terminal, which is combined with a transactivating domain in the C-terminal. In contrast, NF-κB1 and NF-κB2 are processed from large precursors (p105 and p100, respectively) into p50 and p52 subunits. This is a ubiquitin-mediated process, involving selective degradation from the C-terminal to remove ankyrin repeats (Napetschnig and Wu, 2013; Bassères and Baldwin, 2006).

                                As part of the NF-κB signaling pathway, p65 is typically involved in the body’s inflammatory response. This pathway can be induced by stressful stimuli, including free radicals, ultraviolet irradiation (UV),  tumor necrosis factor α (TNFα), interleukin 1-beta (IL-1β), pathogen-associated molecular patterns (PAMPs), or bacterial lipopolysaccharides (LPS). NF-κB has been implicated in memory and synaptic plasticity while aberrant protein levels have been linked to cancer (Courtois et al., 2006; Gutierrez and Davies, 2011).

                                NF-κB pathway following inflammatory signaling

                                In unstimulated cells, NF-κB subunits are restricted to the cytoplasm due to the inhibitory effects of the inhibitor of κB ( IκB) family. IκBα or IκBβ selectively binds to the p50/p65 heterodimer and masks their nuclear localization signal (NLS), preventing their nuclear translocation.

                                Stressful stimuli induce  NF-κB signaling through several cell membrane-bound receptors that converge on the activation of the IκB kinase (IKK) complex. The activated IKK complex phosphorylates IκBα, priming it for subsequent ubiquitylation and proteasome-mediated degradation. Disassociation of IκBα induces NF-κB heterodimers to locate in the nucleus and bind to specific gene promoters to modulate the expression of pro- and anti-inflammatory proteins. As a negative feedback loop, the expression of IκBα and  IκBβ is up-regulated by the NF-κB heterodimers, in order to terminate the signaling pathway.

                                NF-κB subunits have been reported to be extensively modified, including O-linked N-acetyl glycosylation, ubiquitylation, nitrosylation, acetylation, prolyl isomerization, methylation as well as phosphorylation. The best-studied family member is p65 (reviewed by Napetschnig and Wu, 2013; Gilmore, 2006).

                                NF-κB signaling plays a crucial role to fight infections, however, some pathogens have developed ways to alter  NF-κB activity to their advantage. For example, the Human immunodeficiency virus (HIV) contains binding sites within its genome for NF-κB subunits, which drive viral gene expression as well as boosting its replication (Hiscott et al., 2011).

                                Tools for NF-κB research

                                References

                                • Bassères DS, Baldwin AS (2006) Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene. 2006 Oct 30;25(51):6817-30.
                                • Courtois G, Gilmore TD (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease.Oncogene. 2006 Oct 30;25(51):6831-43.
                                • Gilmore TD (2006). Introduction to NF-κB: players, pathways, perspectives.Oncogene 25 (51): 6680–4
                                • Gutierrez H, Davies AM (2011) Regulation of neural process growth, elaboration and structural plasticity by NF-κB.Trends Neurosci. 2011 Jun;34(6):316-25.
                                • Hiscott J, Kwon H, Génin P (2001) Hostile takeovers: viral appropriation of the NF-kappaB pathway.J Clin Invest. 2001 Jan;107(2):143-51
                                • Napetschnig J, Wu H (2013) Molecular basis of NF-κB signaling. Annu Rev Biophys. 2013;42:443-68.
                                • Surjit M, Varshney B, and Lal S (2012) The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells. BMC Biochem. 2012; 13: 7.
                                Get resources and offers direct to your inbox Sign up
                                A-Z by research area
                                • Cancer
                                • Cardiovascular
                                • Cell biology
                                • Developmental biology
                                • Epigenetics & Nuclear signaling
                                • Immunology
                                • Metabolism
                                • Microbiology
                                • Neuroscience
                                • Signal transduction
                                • Stem cells
                                A-Z by product type
                                • Primary antibodies
                                • Secondary antibodies
                                • Biochemicals
                                • Isotype controls
                                • Flow cytometry multi-color selector
                                • Kits
                                • Loading controls
                                • Lysates
                                • Peptides
                                • Proteins
                                • Slides
                                • Tags and cell markers
                                • Tools & Reagents
                                Help & support
                                • Support
                                • Make an Inquiry
                                • Protocols & troubleshooting
                                • Placing an order
                                • RabMAb products
                                • Biochemical product FAQs
                                • Training
                                • Browse by Target
                                Company
                                • Corporate site
                                • Investor relations
                                • Company news
                                • Careers
                                • About us
                                • Blog
                                Events
                                • Tradeshows
                                • Conferences
                                International websites
                                • abcam.cn
                                • abcam.co.jp

                                Join with us

                                • LinkedIn
                                • facebook
                                • Twitter
                                • YouTube
                                • Terms of sale
                                • Website terms of use
                                • Cookie policy
                                • Privacy policy
                                • Legal
                                • Modern slavery statement
                                © 1998-2023 Abcam plc. All rights reserved.